Sex: F
Vaccine: PPV
Symptoms: SARS-CoV-2 antibody test, Urinary tract infection, Vulvovaginal pruritus
Clinical narrative: urine culture (which was positive for a urinary tract infection); bumps across her chest; itching; she was scratching so much that her skin became red and bloody; she was scratching so much that her skin became red and bloody; she was scratching so much that her skin became red and bloody; nothing worked to relieve her itching; damaged her insides; she is full of toxins; she bought over the counter medications for itching, and was prescribed several medications including montelukast; itching eventually developed in her vagina; This spontaneous report was received from a 61-year-old female patient, who was reporting on herself. Her concurrent conditions included unspecified immune system disorder (reported as: not very good immune system), fibromyalgia and chronic fatigue syndrome. She had an allergy to mineral oil/petroleum. Her concomitant therapies included: acyclovir, estrogens, progesterone, quetiapine fumarate(SEROQUEL), clonazepam(CLONOPIN), oxycodone, carisoprodol (SOMA), fentanyl, unspecified "buspor" and "oral pills for yeast". No information regarding the patient's pertinent medical history was provided.  On 19-OCT-2020, the patient was vaccinated with the first dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23), intramuscularly in the left deltoid (strength, dose, lot# and expiry date were not provided) for prophylaxis against pneumococcal disease. On 20-OCT-2020 (reported as the next morning), the patient began experiencing itching and she developed bumps across her chest. The itching was severe, "like chicken pox" and began spreading across her body to her shoulders, breasts, stomach, to her back body and ears. She was scratching so much that on an unknown date in October 2020, her skin became red and bloody. On an unknown date in 2020, the itching eventually developed in the patient's vagina. The patient reported that on an unknown date in 2020, the pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) "damaged her insides" and she was full of toxins. On an unknown dates in 2020, the patient sought medical attention (about 7 appointments total) and consulted with dermatologists, general practitioners and infectious disease doctors. On an unknown dates in 2020, the patient started therapy with other suspect medications including: montelukast sodium (manufacturer unknown), diphenhydramine hydrochloride (BENADRYL), prednisone, hydroxyzine, cortisone, aloe vera, clobetasol propionate and permethrin (for all: formulation, strength, dose, frequency, route of administration, lot# and expiry dates were not provided), all of them for itching. The patient stated that the drugs did not work to relieve her itching. On 18-NOV-2020, the patient sought medical help again and she was given unspecified blood work, urine culture and COVID test for antibodies. On an unknown date in November 2020, she was diagnosed with urinary tract infection, for which she received unspecified antibiotics. The outcome of vulvovaginal pruritus and pruritus was reported as recovering/resolving as of 18-NOV-2020. Outcome of other events was not provided. Action taken with the suspect therapies was not reported. The reporter considered pruritus, skin haemorrhage, erythema, scratch, vulvovaginal pruritus and mass to be not related to montelukast sodium (SINGULAIR). The reporter considered "damaged her insides" (ill-defined disorder) to be related to Pneumococcal Vaccine, Polyvalent (23-valent)(PNEUMOVAX23). The causality assessment between other events and suspect therapies was not provided.